← All indications
Dysthymic Disorder
Chronically depressed mood that occurs for most of the day more days than not for at least 2 years. The required minimum duration in children to make this diagnosis is 1 year. During periods of depressed mood, at least 2 of the following additional symptoms are present: poor appetite or overeating, insomnia or hypersomnia, low energy or fatigue, low self-esteem, poor concentration or difficulty making decisions, and feelings of hopelessness. (DSM-IV)
Drugs by status
Approved for this indication (1)
Phase 4 trials (14)
Phase 2 trials (4)
Other trials (1)
Organizations
Organization Involved with Phase 4 Indications (19)
- Cephalon
- Forest Laboratories
- Eli Lilly
- Pfizer
- GlaxoSmithKline
- National Institute of Mental Health (NIMH)
- Baylor University
- University of Washington
- New York University
- Northwestern University
- Oregon Health and Science University
- St. Luke's-Roosevelt Hospital Center
- University of Miami
- University of Michigan
- Columbia University
- Tel Aviv University
- Icahn School of Medicine at Mount Sinai
- University of Alabama, Birmingham
- Brain & Behavior Research Foundation
Organization Involved with Other Experimental Indications (1)